A seguito dell’approvazione del DECRETO-LEGGE 1 aprile 2021, n. 44 “Misure urgenti per il contenimento dell’epidemia da COVID-19, in materia di vaccinazioni anti SARS-CoV-2, di giustizia e di concorsi pubblici”, che prevede l’applicazione fino al 30 aprile 2021 delle disposizioni del DPCM 2 marzo 2021, si dispone di prorogare le disposizioni previste dalla precedente nota del 04/03/2021 (prot. 0043421).
The meetings of the Scientific Representatives of the drug and of the representatives of medical devices at all the structures of the Company Health Service are therefore suspended until 30 April 2021.
Notwithstanding the above, access is allowed, only in exceptional cases, upon request from the Director of the OU/Service and issue of written authorization from the Medical Director of the facility.
The information activity can still be carried out using alternative methods remotely.
For the moment, the provisions communicated with note prot. 86806 of 06/15/2020, as regards access to the clinics of general practitioners and family pediatricians and to affiliated pharmacies; please note that these provisions recommend preferring remote activities and allow meetings to be held with informers/representatives, exclusively in compliance with the rules set out in the aforementioned note.
These provisions may in any case be subject to modifications, in relation to the evolution of the epidemiological framework and the issuing of further national or local provisions.
Recipients are advised to promptly disseminate, within the scope of their competences, the contents of this letter to all UU.OO. and hospital and territorial services, as well as general practitioners and family paediatricians.
Editor's note: Il piano vaccinale nazionale ha reinserito gli ISF nella fase 1 delle vaccinazioni anti covid-19 considerandolo personale di interesse sanitario che frequenta strutture sanitarie e sociosanitarie, lo stesso dice il DL 44 che, con la stessa dizione, obbliga le regioni e province autonome a vaccinare gli ISF. Ne deriva che il provvedimento dell’APSS Trento non è conforme al DL 44 e può essere impugnato davanti al TAR